1 nal down-modulation of the RANTES receptors, CC chemokine receptor 1 and CC chemokine receptor 5, dur

2                                              CC chemokine receptors 1 and 3 (CCR1 and CCR3) are expre

3 uctures of PXR LBD with Adnectin-1 and CCR1 (CC chemokine receptor-1) antagonist Compound-1 were dete

4 cal laser scanning microscopy showed reduced CC chemokine receptor 1, but not CC chemokine receptor 5

5                                              CC chemokine receptor 1 (CCR1) is expressed in neutrophi

6                                              CC chemokine receptor 1 (CCR1) is found on a variety of

7 dial smooth muscle cells, express functional CC chemokine receptor-1 (CCR1) and respond to RANTES by

8                                          The CC chemokine receptor-1 (CCR1) is a prime therapeutic ta

9 essing a hemagglutinin-tagged version of the CC-chemokine receptor 1 (CCR1), and using these reagents

10 ession (IL-2, -4, -6, -10, and IFN-gamma and CC chemokine receptor-1 [CCR1]) was assayed in the lymph

11                                    The total CC chemokine receptor 1 pool (surface and intracellular

12 ES was directly correlated with the level of CC chemokine receptor 1 surface expression.

13 inal tail), and 2) the N-terminal segment of CC chemokine receptor 1, which does not bind CXC chemoki